Kuz’min, V.E., Lozitsky, V.P., Kamalov, G.L., Lozitskaya, R.N., Zheltvay, A.I., Fedtchouk, A.S. and Kryzhanovsky, D.N. (2000) Analysis of the Structure—Anticancer Activity Relationship in a Set of Schiff Bases of Macrocyclic 2,6-Bis(2- and 4-formylaryloxymethyl)pyridines. Acta Biochimica Polonica, 47, 867-875.

has been cited by the following article:

• TITLE: α-Glucosidase Inhibition by New Schiff Base Complexes of Zn(II)

  AUTHORS: Rie Miyazaki, Hiroyuki Yasui, Yutaka Yoshikawa

  KEYWORDS: α-Glucosidase Inhibitory Effect, Zn(II) Complexes, Schiff Bases, Diabetes Mellitus

  JOURNAL NAME: Open Journal of Inorganic Chemistry, Vol.6 No.2, April 12, 2016

  ABSTRACT: There are many reports that divalent alkaline earth, first-row transition metals, and Zn(II) ions have α-glucosidase inhibitory effects. Cu(II) and Zn(II) ions, in particular, have strong α-glucosidase inhibitory effects. Several Schiff bases also display α-glucosidase inhibitory effects. In this study, we focused on safe and highly effective complexes including Zn(II) ion. We prepared and characterized the Zn(II) complexes with four different Schiff bases (N-salicylidene-β-alanine (N-sβ), N-N’-bis (salicylidene) ethylenediamine (N-bsE), N, N’-bis (salicylidene)-phenylenediamine (N-bsP), and 1-[(2-dimethylaminoethylimino) methyl]naphtholate (DMN)) and investigated their α-glucosidase inhibitory effects in vitro, using α-glycosidases from Saccharomyces sp. and rat small intestine, and in vivo, using a sucrose tolerance test. The Zn(II) complexes with DMN showed the highest in vitro and in vivo α-glucosidase inhibitory effects in this study.